Author

Jay-Jiguang Zhu

Institution: The University of Texas Health Science Center at Houston

Observed institution: The University of Texas Health Science Center at Houston

OpenAlex ID: A5137150902

Pooled analysis of phase I and expanded access study cohorts of DOC1021 (dubodencel) in combination with chemoradiation for glioblastoma.

2026 · Jay-Jiguang Zhu, Sigmund H. Hsu, et al. · Journal of Clinical Oncology

Change in relative cerebral blood volume as a biomarker for early response to bevacizumab in patients with recurrent glioblastoma: ECOG-ACRIN EAF151.

2026 · Jerrold L. Boxerman, Bradley S. Snyder, et al. · Journal of Clinical Oncology

Works count: 2

Citation count:

H-index:

I10-index: